Finn BAUER,Thorsten WEDEL,Guenter MODDELMOG,Gudrun BIRK,Roberto OGNIBENE,Dieter LUBDA
申请号：
US16854516
公开号：
US20200246270A1
申请日:
2020.04.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
